person

Pierre-Louis C.

Country
France
Department
N/A

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
177
Sites with multiple studies

Has run more than one trial at 177 of 689 partner sites.

Specializations

Kidney Disease Management

This investigator specializes in treating various forms of chronic kidney disease, with particular emphasis on conditions involving high proteinuria. Their research encompasses innovative therapeutic approaches for IgA nephropathy and kidney disease associated with type 2 diabetes.

  • Proteinuria Management
  • Diabetic Kidney Disease
  • Progressive Renal Function Loss

The investigator's work explores combined therapeutic strategies using novel agents to slow kidney function decline.

Autoimmune Disorders

The investigator has significant expertise in treating autoimmune vasculitis conditions, particularly focusing on ANCA-associated vasculitis and IgA vasculitis. Their research includes evaluation of immunosuppressive therapies and novel treatment approaches.

  • Vasculitis Treatment
  • Immunosuppressive Therapy
  • Renal Vasculitis Management

Their work includes assessment of therapeutic interventions for newly-diagnosed and relapsing cases.

Cardiovascular-Renal Medicine

The investigator focuses on the intersection of hypertension and kidney disease, investigating therapeutic approaches for patients with uncontrolled hypertension in the context of moderate to severe kidney disease. Their expertise extends to end-stage renal disease management.

  • Blood Pressure Management
  • Cardiovascular Risk in Kidney Disease
  • Diuretic-Based Interventions

Their research evaluates strategies to prevent cardiovascular events and mortality in kidney disease patients.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.